171 related articles for article (PubMed ID: 12496253)
1. The factor IX gamma-carboxyglutamic acid (Gla) domain is involved in interactions between factor IX and factor XIa.
Aktimur A; Gabriel MA; Gailani D; Toomey JR
J Biol Chem; 2003 Mar; 278(10):7981-7. PubMed ID: 12496253
[TBL] [Abstract][Full Text] [Related]
2. First epidermal growth factor-like domain of human blood coagulation factor IX is required for its activation by factor VIIa/tissue factor but not by factor XIa.
Zhong D; Smith KJ; Birktoft JJ; Bajaj SP
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3574-8. PubMed ID: 8170949
[TBL] [Abstract][Full Text] [Related]
3. Membrane binding properties of the factor IX gamma-carboxyglutamic acid-rich domain prepared by chemical synthesis.
Jacobs M; Freedman SJ; Furie BC; Furie B
J Biol Chem; 1994 Oct; 269(41):25494-501. PubMed ID: 7929250
[TBL] [Abstract][Full Text] [Related]
4. The mechanism underlying activation of factor IX by factor XIa.
Gailani D; Geng Y; Verhamme I; Sun MF; Bajaj SP; Messer A; Emsley J
Thromb Res; 2014 May; 133 Suppl 1(0 1):S48-51. PubMed ID: 24759143
[TBL] [Abstract][Full Text] [Related]
5. Modification of the N-terminus of human factor IX by defective propeptide cleavage or acetylation results in a destabilized calcium-induced conformation: effects on phospholipid binding and activation by factor XIa.
Wojcik EG; Van Den Berg M; Poort SR; Bertina RM
Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):629-36. PubMed ID: 9169594
[TBL] [Abstract][Full Text] [Related]
6. gamma-Carboxyglutamic acids 36 and 40 do not contribute to human factor IX function.
Gillis S; Furie BC; Furie B; Patel H; Huberty MC; Switzer M; Foster WB; Scoble HA; Bond MD
Protein Sci; 1997 Jan; 6(1):185-96. PubMed ID: 9007991
[TBL] [Abstract][Full Text] [Related]
7. Characterization of gamma-carboxyglutamic acid residue 21 of human factor IX.
Wolberg AS; Li L; Cheung WF; Hamaguchi N; Pedersen LG; Stafford DW
Biochemistry; 1996 Aug; 35(32):10321-7. PubMed ID: 8756687
[TBL] [Abstract][Full Text] [Related]
8. Factor IX of the blood coagulation system: a review.
Taran LD
Biochemistry (Mosc); 1997 Jul; 62(7):685-93. PubMed ID: 9331959
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the calcium-stabilized human factor IX Gla domain bound to a conformation-specific anti-factor IX antibody.
Huang M; Furie BC; Furie B
J Biol Chem; 2004 Apr; 279(14):14338-46. PubMed ID: 14722079
[TBL] [Abstract][Full Text] [Related]
10. Identification of a factor IX binding site on the third apple domain of activated factor XI.
Sun Y; Gailani D
J Biol Chem; 1996 Nov; 271(46):29023-8. PubMed ID: 8910554
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Novel Forms of Coagulation Factor XIa: independence of factor XIa subunits in factor IX activation.
Smith SB; Verhamme IM; Sun MF; Bock PE; Gailani D
J Biol Chem; 2008 Mar; 283(11):6696-705. PubMed ID: 18192270
[TBL] [Abstract][Full Text] [Related]
12. Localization of a heparin binding site in the catalytic domain of factor XIa.
Badellino KO; Walsh PN
Biochemistry; 2001 Jun; 40(25):7569-80. PubMed ID: 11412111
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of the recombinant factor VIIa in rat bone: importance of the Gla-domain and relevance to factor IX, another vitamin K-dependent clotting factor.
Thomsen MK; Wildgoose P; Nilsson P; Hedner U
Pharmacol Toxicol; 1993 Sep; 73(3):127-32. PubMed ID: 7903449
[TBL] [Abstract][Full Text] [Related]
14. Identification of the phospholipid binding site in the vitamin K-dependent blood coagulation protein factor IX.
Freedman SJ; Blostein MD; Baleja JD; Jacobs M; Furie BC; Furie B
J Biol Chem; 1996 Jul; 271(27):16227-36. PubMed ID: 8663165
[TBL] [Abstract][Full Text] [Related]
15. Identification and chemical synthesis of a substrate-binding site for factor IX on coagulation factor XIa.
Baglia FA; Jameson BA; Walsh PN
J Biol Chem; 1991 Dec; 266(35):24190-7. PubMed ID: 1748688
[TBL] [Abstract][Full Text] [Related]
16. Exosite-mediated substrate recognition of factor IX by factor XIa. The factor XIa heavy chain is required for initial recognition of factor IX.
Ogawa T; Verhamme IM; Sun MF; Bock PE; Gailani D
J Biol Chem; 2005 Jun; 280(25):23523-30. PubMed ID: 15829482
[TBL] [Abstract][Full Text] [Related]
17. Role of the propeptide and gamma-glutamic acid domain of factor IX for in vitro carboxylation by the vitamin K-dependent carboxylase.
Stanley TB; Wu SM; Houben RJ; Mutucumarana VP; Stafford DW
Biochemistry; 1998 Sep; 37(38):13262-8. PubMed ID: 9748333
[TBL] [Abstract][Full Text] [Related]
18. Binding properties of the coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis.
Atoda H; Yoshida N; Ishikawa M; Morita T
Eur J Biochem; 1994 Sep; 224(2):703-8. PubMed ID: 7925387
[TBL] [Abstract][Full Text] [Related]
19. Profactor IX: the propeptide inhibits binding to membrane surfaces and activation by factor XIa.
Bristol JA; Freedman SJ; Furie BC; Furie B
Biochemistry; 1994 Nov; 33(47):14136-43. PubMed ID: 7947825
[TBL] [Abstract][Full Text] [Related]
20. The endothelial cell binding determinant of human factor IX resides in the gamma-carboxyglutamic acid domain.
Toomey JR; Smith KJ; Roberts HR; Stafford DW
Biochemistry; 1992 Feb; 31(6):1806-8. PubMed ID: 1310619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
